Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 9, 2006
J Am Soc Nephrol 17: 2402-2413, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005111197

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005111197v1
17/9/2402    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Reilly, M.
Right arrow Articles by Brown, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Reilly, M.
Right arrow Articles by Brown, R. W.
Related Collections
Right arrowRelated Article

Cell and Transport Physiology

Dietary Electrolyte–Driven Responses in the Renal WNK Kinase Pathway In Vivo

Michelle O’Reilly*, Elaine Marshall*, Thomas MacGillivray{dagger}, Manish Mittal*, Wei Xue*, Chris J. Kenyon* and Roger W. Brown*

* Endocrinology, Centre for Cardiovascular Science, Queen’s Medical Research Institute, and {dagger} Wellcome Trust Clinical Research Facility, Western General Hospital, Edinburgh, United Kingdom

Address correspondence to: Dr. Roger W. Brown, Centre for Cardiovascular Science, Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, UK EH16 4TJ. Phone: +44-1312426739/6777; Fax: +44-1312426779; E-mail: roger.brown{at}ed.ac.uk

Received for publication November 18, 2005. Accepted for publication June 11, 2006.

WNK1 and WNK4 are unusual serine/threonine kinases with atypical positioning of the catalytic active-site lysine (WNK: With-No-K[lysine]). Mutations in these WNK kinase genes can cause familial hyperkalemic hypertension (FHHt), an autosomal dominant, hypertensive, hyperkalemic disorder, implicating this novel WNK pathway in normal regulation of BP and electrolyte balance. Full-length (WNK1-L) and short (WNK1-S) kinase-deficient WNK1 isoforms previously have been identified. Importantly, WNK1-S is overwhelmingly predominant in kidney. Recent Xenopus oocyte studies implicate WNK4 in inhibition of both thiazide-sensitive co-transporter–mediated Na+ reabsorption and K+ secretion via renal outer medullary K+ channel and now suggest that WNK4 is inhibited by WNK1-L, itself inhibited by WNK1-S. This study examined WNK pathway gene expression in mouse kidney and its regulation in vivo. Expression of WNK1-S and WNK4 is strongest in distal tubule, dropping sharply in collecting duct and with WNK4 also expressed in thick ascending limb and the macula densa. These nephron segments that express WNK1-S and WNK4 mRNA have major influence on long-term NaCl reabsorption, BP, K+, and acid-base balance, processes that all are disrupted in FHHt. In vivo, this novel WNK pathway responds with significant upregulation of WNK1-S and WNK4 with high K+ intake and reduction in WNK1-S on chronic lowering of K+ or Na+ intake. A two-compartment distal nephron model explains these in vivo findings and the pathophysiology of FHHt well, with WNK and classic aldosterone pathways responding to drivers from K+ balance, extracellular volume, and aldosterone and cross-talk through distal Na+ delivery regulating electrolyte balance and BP.


Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2006 17: 2343-2344. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. San-Cristobal, J. Ponce-Coria, N. Vazquez, N. A. Bobadilla, and G. Gamba
WNK3 and WNK4 amino-terminal domain defines their effect on the renal Na+-Cl- cotransporter
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1199 - F1206.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Estilo, W. Liu, N. Pastor-Soler, P. Mitchell, M. D. Carattino, T. R. Kleyman, and L. M. Satlin
Effect of aldosterone on BK channel expression in mammalian cortical collecting duct
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F780 - F788.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. McCormick, C.-L. Yang, and D. H. Ellison
WNK Kinases and Renal Sodium Transport in Health and Disease: An Integrated View
Hypertension, March 1, 2008; 51(3): 588 - 596.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J.-B. Peng and D. G. Warnock
WNK4-mediated regulation of renal ion transport proteins
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F961 - F973.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Verrey
WNK4, as thiazides, shuts off NaCl reabsorption to stimulate Na/K exchange
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1305 - 1308.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Garzon-Muvdi, D. Pacheco-Alvarez, K. B. E. Gagnon, N. Vazquez, J. Ponce-Coria, E. Moreno, E. Delpire, and G. Gamba
WNK4 kinase is a negative regulator of K+-Cl- cotransporters
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1197 - F1207.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP